The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's antipsychotic drug in combination with Viatris' antidepressant Zoloft for ...

There's an unmet need for effective treatments in PTSD, as current options include psychotherapy and the SSRIs sertraline and paroxetine (Paxil). These options carry various adverse effects, and the ...

The CAPS-5 total score ranks severity of 20 PTSD symptoms from 0 (not present) to 80 (most severe). Baseline values for the ...

Present-centered therapy (PCT) is a non-trauma, manualized psychotherapy for adults with post-traumatic stress disorder (PTSD). PCT was originally designed as a treatment comparator in trials ...

A boy charged with manslaughter and other crimes after accidentally shooting and killing his 15-year-old cousin will no ...

A controversial treatment offers a painless route to ridding veterans of their trauma responses. But does it really work?

FDA reviewers flag "discordant results" in a briefing document published ahead of Friday's advisory committee meeting for the ...

The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with post-traumatic stress disorder (PTSD) ...

Otsuka Pharma (OTCPK:OTSKY) and H. Lundbeck (OTCPK:HLBBF) draws efficacy concerns for their PTSD therapy from the FDA ahead ...

The Center of Family Services of Palm Beach County is the only facility in the area providing "Reconsolidation of Traumatic Memories" (RTM) therapy, which is transforming the lives of those living ...

University of Leeds psychologists report that stress appraisal and perceived stress act as key conduits linking childhood ...

An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...